Indication
Progressive keratoconus
Progressive keratoconus is an active, worsening corneal ectatic disorder affecting the ocular system, most commonly emerging in adolescence or early adulthood. Read more about Progressive keratoconus
6 drugs 2 manufacturers
Drugs that treat it
Common Progressive keratoconus therapies.
PHOTREXA (riboflavin 5-phosphate sodium (B2))
PHOTREXA CROSS-LINKING (riboflavin 5-phosphate sodium in 20 % dextran)
PHOTREXA VISCOUS (riboflavin 5-phosphate sodium in 20 % dextran)
PHOTREXA (riboflavin 5-phosphate sodium (B2))
EPIOXA (riboflavin 5-phosphate sodium (B2))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProgressive keratoconus is an active, worsening corneal ectatic disorder affecting the ocular system, most commonly emerging in adolescence or early adulthood.
It is characterized by continuing biomechanical instability and degradation of the corneal stroma, resulting in noninflammatory structural thinning and conical protrusion of the central or paracentral cornea.
Clinically, active progression is confirmed through serial topography or tomography demonstrating documented increases in corneal steepening, progressive stromal thinning, and worsening irregular astigmatism and myopia.
Left unchecked, this progression causes advancing visual distortion, diminished best-corrected visual acuity, and potentially debilitating corneal scarring.
- nih.gov
Progressive keratoconus is an active, worsening corneal ectatic disorder affecting the ocular system, most commonly emerging in adolescence or early adulthood Left unchecked, this progression causes advancing visual distortion, diminished best-corrected visual acuity, and potentially debilitating corneal scarring
- evolutionaryeyecare.com
Progressive keratoconus is an active, worsening corneal ectatic disorder affecting the ocular system, most commonly emerging in adolescence or early adulthood
- aao.org
It is characterized by continuing biomechanical instability and degradation of the corneal stroma, resulting in noninflammatory structural thinning and conical protrusion of the central or paracentral cornea Clinically, active progression is confirmed through serial topography or tomography demonstrating documented increases in corneal steepening, progressive stromal thinning, and worsening irregular astigmatism and myopia
- nih.gov
Clinically, active progression is confirmed through serial topography or tomography demonstrating documented increases in corneal steepening, progressive stromal thinning, and worsening irregular astigmatism and myopia
- vision-institute.com
Clinically, active progression is confirmed through serial topography or tomography demonstrating documented increases in corneal steepening, progressive stromal thinning, and worsening irregular astigmatism and myopia
- nih.gov
Left unchecked, this progression causes advancing visual distortion, diminished best-corrected visual acuity, and potentially debilitating corneal scarring
- clevelandclinic.org
Left unchecked, this progression causes advancing visual distortion, diminished best-corrected visual acuity, and potentially debilitating corneal scarring
Personalize your experience
Follow Progressive keratoconus and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.